Equities research analysts predict that Kindred Healthcare, Inc. (NYSE:KND) will report $1.46 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Kindred Healthcare’s earnings. Kindred Healthcare reported sales of $1.79 billion during the same quarter last year, which would suggest a negative year-over-year growth rate of 18.4%. The business is expected to issue its next earnings results after the market closes on Monday, November 6th.

According to Zacks, analysts expect that Kindred Healthcare will report full year sales of $1.46 billion for the current year, with estimates ranging from $5.98 billion to $6.02 billion. For the next fiscal year, analysts forecast that the business will post sales of $6.04 billion per share, with estimates ranging from $6.02 billion to $6.06 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Kindred Healthcare.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm posted $0.38 EPS. Kindred Healthcare’s quarterly revenue was down 4.6% on a year-over-year basis.

KND has been the topic of several analyst reports. Deutsche Bank AG dropped their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday, August 7th. Zacks Investment Research raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. BidaskClub cut Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Mizuho reissued a “neutral” rating and issued a $9.00 price target on shares of Kindred Healthcare in a research note on Monday, July 3rd. Finally, Royal Bank Of Canada decreased their price target on Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating for the company in a research note on Thursday, September 21st. Six investment analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $8.75.

Shares of Kindred Healthcare (NYSE KND) opened at 6.05 on Friday. The stock’s market capitalization is $526.46 million. Kindred Healthcare has a 12 month low of $5.50 and a 12 month high of $11.90. The firm’s 50 day moving average is $6.55 and its 200 day moving average is $8.84.

TRADEMARK VIOLATION NOTICE: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/10/29/zacks-analysts-expect-kindred-healthcare-inc-knd-will-post-quarterly-sales-of-1-46-billion.html.

Several large investors have recently added to or reduced their stakes in KND. Janus Henderson Group PLC bought a new position in shares of Kindred Healthcare in the second quarter worth $130,000. Two Sigma Securities LLC boosted its stake in Kindred Healthcare by 54.5% during the first quarter. Two Sigma Securities LLC now owns 15,632 shares of the health services provider’s stock valued at $131,000 after buying an additional 5,511 shares in the last quarter. Paloma Partners Management Co bought a new position in Kindred Healthcare during the first quarter valued at about $133,000. Amalgamated Bank boosted its stake in Kindred Healthcare by 0.9% during the second quarter. Amalgamated Bank now owns 11,518 shares of the health services provider’s stock valued at $134,000 after buying an additional 108 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Kindred Healthcare by 28.1% during the first quarter. SG Americas Securities LLC now owns 20,915 shares of the health services provider’s stock valued at $175,000 after buying an additional 4,584 shares in the last quarter. 87.55% of the stock is owned by institutional investors.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.